Capital International Sarl’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-64,970
| Closed | -$4.29M | – | 289 |
|
|
2024
Q3 | $4.29M | Buy |
64,970
+8,115
| +14% | +$536K | 0.11% | 136 |
|
|
2024
Q2 | $5.25M | Sell |
56,855
-5,606
| -9% | -$518K | 0.16% | 125 |
|
|
2024
Q1 | $5.97M | Sell |
62,461
-17,656
| -22% | -$1.69M | 0.2% | 113 |
|
|
2023
Q4 | $6.11M | Sell |
80,117
-90,546
| -53% | -$6.9M | 0.23% | 105 |
|
|
2023
Q3 | $11.8M | Sell |
170,663
-1,775
| -1% | -$123K | 0.54% | 62 |
|
|
2023
Q2 | $16.3M | Buy |
172,438
+14,653
| +9% | +$1.38M | 0.73% | 43 |
|
|
2023
Q1 | $13.1M | Buy |
157,785
+66,237
| +72% | +$5.48M | 0.66% | 47 |
|
|
2022
Q4 | $6.83M | Buy |
91,548
+13,540
| +17% | +$1.01M | 0.48% | 72 |
|
|
2022
Q3 | $6.45M | Buy |
78,008
+7,712
| +11% | +$637K | 0.52% | 62 |
|
|
2022
Q2 | $6.68M | Sell |
70,296
-25,571
| -27% | -$2.43M | 0.54% | 57 |
|
|
2022
Q1 | $11.3M | Buy |
95,867
+2,388
| +3% | +$281K | 0.56% | 51 |
|
|
2021
Q4 | $12.1M | Buy |
93,479
+40,994
| +78% | +$5.31M | 0.58% | 44 |
|
|
2021
Q3 | $5.94M | Sell |
52,485
-4,322
| -8% | -$489K | 0.53% | 61 |
|
|
2021
Q2 | $5.88M | Buy |
56,807
+10,545
| +23% | +$1.09M | 0.51% | 63 |
|
|
2021
Q1 | $3.87M | Buy |
46,262
+15,610
| +51% | +$1.31M | 0.37% | 85 |
|
|
2020
Q4 | $2.8M | Buy |
30,652
+5,933
| +24% | +$541K | 0.29% | 99 |
|
|
2020
Q3 | $1.97M | Buy |
24,719
+480
| +2% | +$38.3K | 0.24% | 103 |
|
|
2020
Q2 | $1.68M | Buy |
24,239
+284
| +1% | +$19.6K | 0.22% | 100 |
|
|
2020
Q1 | $1.51M | Sell |
23,955
-39,555
| -62% | -$2.49M | 0.27% | 94 |
|
|
2019
Q4 | $4.94M | Buy |
63,510
+4,260
| +7% | +$331K | 0.77% | 46 |
|
|
2019
Q3 | $4.34M | Buy |
+59,250
| New | +$4.34M | 0.75% | 46 |
|